Ekso Bionics Details 97% Dilutive Reverse Merger into AI Cloud Business, $15M Financing, and New Equity Plan

summarizeSummary

This filing provides comprehensive details regarding the previously announced reverse merger where Ekso Bionics will acquire Applied Digital Cloud Corporation, a subsidiary of Applied Digital Corporation. The transaction will result in approximately 97% dilution for existing Ekso shareholders, who will collectively own only about 3% of the combined entity, to be renamed ChronoScale Corporation. The filing also outlines a new $15 million equity financing from Applied Parent and the adoption of a new equity incentive plan authorizing 22.5 million shares. This transformative event, driven by Ekso's 'going concern' warning, fundamentally alters the company's business and ownership structure, shifting its focus to AI cloud computing. The substantial dilution and change in control are highly significant for current investors.

check_boxKey Events

• Reverse Merger Details Confirmed

  Ekso Bionics will acquire Applied Digital Cloud Corporation, a subsidiary of Applied Digital Corporation, in a reverse merger. The combined entity will be renamed ChronoScale Corporation and focus on AI cloud computing.

• Massive Shareholder Dilution

  Existing Ekso Bionics shareholders are expected to collectively hold approximately 3% of the combined company's outstanding common stock, while the acquirer (Contributor) will hold 96% and Applied Parent 1%.

• $15 Million Equity Financing

  Applied Digital Corporation will subscribe for and purchase at least $15 million of common stock in a private placement immediately prior to the merger closing, at an assumed price of $11.81 per share.

• New Equity Incentive Plan Adopted

  A new 2026 Omnibus Equity Incentive Plan has been approved, authorizing the issuance of 22,500,000 shares of common stock for eligible employees, officers, and directors of ChronoScale Corporation.

auto_awesomeAnalysis

This filing provides comprehensive details regarding the previously announced reverse merger where Ekso Bionics will acquire Applied Digital Cloud Corporation, a subsidiary of Applied Digital Corporation. The transaction will result in approximately 97% dilution for existing Ekso shareholders, who will collectively own only about 3% of the combined entity, to be renamed ChronoScale Corporation. The filing also outlines a new $15 million equity financing from Applied Parent and the adoption of a new equity incentive plan authorizing 22.5 million shares. This transformative event, driven by Ekso's 'going concern' warning, fundamentally alters the company's business and ownership structure, shifting its focus to AI cloud computing. The substantial dilution and change in control are highly significant for current investors.